Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zyrtec Model Shows Managed Care’s “Softer” Side For Switching Patients

This article was originally published in The Tan Sheet

Executive Summary

Sales of Johnson & Johnson's allergy drug Zyrtec show managed care organizations learned from previous switches and used a "softer" approach to steer clients away from Rx drugs to an OTC product, according to market analysts
Advertisement

Related Content

DTC Spending During Rx Life Yields OTC Switch Market Share
DTC Spending During Rx Life Yields OTC Switch Market Share
DTC Spending During Rx Life Yields OTC Switch Market Share
DTC Spending During Rx Life Yields OTC Switch Market Share
Drugstore.com And Medco Online Store Widen Range Of OTC Niche Offerings
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
J&J Zyrtec Pediatric Spoon Marks Increased Role For Dosing Innovations
Prevacid Initial Launch Efforts To Focus On Switching Prescription Users
Zyrtec OTC Launch Does Not Deliver Knockout To Rx Remedies – Report
Zegerid on track

Topics

Advertisement
UsernamePublicRestriction

Register

PS102370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel